Cost Analysis of FreeStyle Libre ® 2 System in Type 2 Diabetes Mellitus Population
Oyagüez, Itziar (Pharmacoeconomics and Outcomes Research Iberia (PORIB))
Gómez-Peralta, Fernando (Hospital General de Segovia)
Artola, Sara (Centro de Salud José Marvá, Madrid)
Carrasco Trancoso, Francisco Javier (Universitat de Girona)
Carretero-Gómez, Juana (Hospital de Zafra, Badajoz)
García-Soidan, Javier (Centro de Saúde do Porriño)
Gomez Huelgas, Ricardo (Hospital Regional Universitario de Málaga)
Merino-Torres, Juan F. (Hospital Universitari i Politècnic La Fe (València))
Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau)
Universitat Autònoma de Barcelona

Data:	2021
Resum:	FreeStyle Libre ® 2 system is a sensor-based flash-monitoring system that measures interstitial fluid glucose. The study aimed to compare cost of FreeStyle Libre 2 system and self-monitoring of blood glucose (SMBG) in the type 2 diabetes mellitus (T2DM) population from the Spanish Health System perspective. On the basis of data collected from a literature review, the cost of glucose monitoring was modelled for patients with T2DM on a basal-bolus insulin regimen. The cost estimate included annual consumption for glucose monitoring (strips, lancets and sensors) and severe hypoglycaemic events (SHE) management. A published rate of SHE (2. 5 episodes/patient-year) was considered. A reduction of SHE (− 48. 8%) associated with FreeStyle Libre 2 system, derived from the REPLACE trial, was applied. Hospital attendance for 20. 5% of SHEs (with subsequent hospitalization in 16. 0%) was applied. Consumption of strips and lancets was set at 6/day for SMBG (derived from national monitoring recommendations), and 0. 2/day for FreeStyle Libre 2 system users, with 26 FreeStyle Libre 2 sensors/year. Unitary costs (€, year 2020 excluding VAT) were derived from literature (€0. 28/strip; €0. 09/lancet; €3. 09/daily FM sensor; €3804/hospitalized SHE; €1794/hospital-attended non-admitted SHE; €389/community-attended SHE). Costs were €2700 and €2120/year/patient using SMBG or FreeStyle Libre 2 system, respectively. For 1000 patients with T2DM using basal-bolus insulin, 1220 SHEs/year (with 48 hospitalizations) could be prevented and FreeSytle Libre 2 system could generate cost savings of up to €580,953/year versus SMBG (− 21. 5%). FreeStyle Libre 2 system is a potential cost-saving strategy in patients with T2DM in Spain on a basal-bolus insulin regimen.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Cost ; Diabetes ; Flash ; FreeStyle Libre ; Glucose monitoring
Publicat a:	Diabetes Therapy, may 2021, p. 1-14, ISSN 1869-6961

DOI: 10.1007/s13300-021-01064-4
PMID: 33948909

14 p, 455.4 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats